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Summary
Objective: In humans, mutations of the γ‐aminobutyric acid receptor subunit 1
(GABRA1) cause either mild or severe generalized epilepsy. Although these epi-
lepsy‐causing mutations have been shown to disrupt the receptor activity in vitro,
their in vivo consequences on brain development and activity are not known. Here,
we aim at unraveling the epileptogenesis mechanisms of GABRA1 loss of function.
Methods: We generated a gabra1−/− zebrafish mutant line displaying highly pen-
etrant epileptic seizures. We sought to identify the underlying molecular mecha-
nisms through unbiased whole transcriptomic assay of gabra1−/− larval brains.
Results: Interestingly, mutant fish show fully penetrant seizures at juvenile stages
that accurately mimic tonic–clonic generalized seizures observed in patients. More-
over, highly penetrant seizures can be induced by light stimulation, thus providing
us with the first zebrafish model in which evident epileptic seizures can be induced
by nonchemical agents. Our transcriptomic assay identified misregulated genes in
several pathways essential for correct brain development. More specifically, we
show that the early development of the brain inhibitory network is specifically
affected. Although the number of GABAergic neurons is not altered, we observed
a drastic reduction in the number of inhibitory synapses and a decreased complex-
ity of the GABAergic network. This is consistent with the disruption in expression
of many genes involved in axon guidance and synapse formation.
Significance: Together with the role of GABA in neurodevelopment, our data
identify a novel aspect of epileptogenesis, suggesting that the substratum of
GABRA1‐deficiency epilepsy is a consequence of early brain neurodevelopmental
defects, in particular at the level of inhibitory network wiring.
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1 | INTRODUCTION
In the past decades, much effort has been deployed in try-
ing to unravel the genetic origins of idiopathic forms of
epilepsy, which represent more than two‐thirds of all
epilepsies.1 Among the causative genes identified in
patients, mutations in several γ‐aminobutyric acid (GABA)
receptor subunits (alpha1, alpha6, beta2, beta3, gamma2,
and delta) have been characterized in patients suffering
from epilepsy.2,3 In particular, mutations in the GABA type
A receptor (GABARA) subunit alpha 1 (GABRA1) have
been identified as causative of juvenile myoclonic epilep-
sies,4 idiopathic generalized epilepsies,3,5 and more
recently, Dravet syndrome.6 GABA is the main inhibitory
neurotransmitter in the adult brain, and it acts by binding
to pentameric receptors and ligand‐gated chloride channels
whose activation leads to hyperpolarization of neurons.7
The identification of several epilepsy‐causing mutations in
genes encoding GABA receptor subunits and associated
proteins was taken as direct evidence linking defective
GABA inhibition with neuronal overexcitation.4,8 However,
GABA signaling has been shown also to display key regu-
latory functions during neurogenesis and early brain devel-
opment.9,10 At early developmental stages, due to a high
intracellular chloride level, GABA is able to depolarize
neuronal cells. Many studies showed that this early depo-
larizing effect of GABA regulates a broad range of pro-
cesses from formation and maturation of neuronal circuits,9
in particular, early GABAergic synaptogenesis.11
Therefore, it is likely that epilepsy‐causing mutations
impairing GABRA1 function not only impact the excita-
tory/inhibitory balance in the brain, but may also disrupt
early brain development and/or the maturation of specific
neuronal networks. However, in the context of epilepsy,
the effects of GABA receptor loss of function on embryo
brain development and their relevance to the disease are
still poorly studied in vivo. In mice, deletion of GABAA
receptor α1 subunits results in the loss of half of all
GABAA receptors in the brain.
12 Interestingly, the
homozygous knockout (KO) mouse only displays a tre-
mor phenotype,13 suggesting that mammalian models
only display a limited relevance to the disease and that
alternative genetic models of GABRA1‐KO are urgently
needed.
Here, we generated a zebrafish model of GABRA1 loss
of function displaying fully penetrant generalized seizures
at juvenile stages, which accurately mimic those observed
in patients. This behavior is associated with an increase in
the neuronal activity that we quantified in vivo using a
calcium‐dependent fluorescent reporter line. RNA‐sequen-
cing analysis of gabra1−/− larval brains identified a
marked down‐regulation of genes encoding inhibitory
synapse components as well as proteins involved in axon
guidance. Consistently, immunocytochemical analysis of
gabra1−/− embryos revealed a marked decrease in the
accumulation of GABA synapse markers. Altogether, our
results reveal in vivo the neurodevelopmental defects that
are likely to be causative factors for GABRA1 loss‐of‐func-
tion epileptogenesis.
2 | MATERIALS AND METHODS
2.1 | Fish husbandry and fish lines
Wild‐type Danio rerio were reared at 28.5°C, kept under a
12‐hour dark, 12‐hour light cycle, and staged as described
previously.14 All experiments were performed in compli-
ance with the guidelines of the Canadian Council for Ani-
mal Care and conducted at the Research Center of the
University of Montreal Hospital Center. The NeuroD:
GCaMP6F transgenic line is a gift from Claire Wyart.15
2.2 | Whole mount in situ hybridization and
probe cloning
A specific 854‐bp gabra1 probe was cloned within the
pCS2+ vector using the TOPO TA cloning kit (Invitrogen,
Carlsbad, California). Whole mount in situ hybridization of
zebrafish embryos was performed as described previ-
ously.16
2.3 | sgRNA and Cas9 preparation and
microinjection
A gRNA sequence was designed using the online tool
CRISPRscan (protospacer adjacent motif site in parenthe-
ses): GCCGTTGTGGAAGAACGTGT(CGG). Synthesis of
gRNA and Cas9 mRNA as well as embryo microinjection
was performed as described previously.16
Key Points
• Gabra1 loss of function causes epileptic seizures
that can be triggered by light in zebrafish
• Seizures of gabra1−/− can be alleviated by
canonical antiepileptics such as clonazepam but
not carbamazepine
• Gabra1−/− embryos are suitable for high-
throughput antiepileptic drug screening
• Gabra1 loss of function causes broad changes in
the larval brain transcriptome
• Gabra1 specifically regulates the development of
the inhibitory neuronal network that is impaired
in gabra1−/− brains
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2.4 | Fish tracking and seizure triggering
A DanioVision (Noldus, Wageningen, The Netherlands)
setup was used as a lightproof recording chamber with an
infrared camera. Seizures were induced after 1 hour spent
in darkness and by switching on the built‐in cold‐white
light‐emitting diode light for at least 1 minute. Ethovision
XT12 (Noldus) was used for analyzing the distance swam
and maximum acceleration as well as to extract swimming
tracks.
2.5 | GCaMP6F monitoring and fluorescence
quantification
Larvae were immobilized dorsal side up in 1% low‐melting
agarose and placed under a spinning disk confocal micro-
scope. The embedded fish was kept in complete darkness
for at least 30 minutes. Seizure was triggered by switching
on the laser, and fluorescence was recorded on a single
focal plan for 60 seconds at a rate of 2.5 images per sec-
ond. Fluorescence quantification from the optic tecta was
performed using the mean gray value measurement from an
8‐bit image (ImageJ, NIH, Bethesda, Maryland). All gray
values were normalized against a resting basal mean gray
value.
2.6 | Antiepileptic drug treatment
All solutions were prepared extemporaneously as follow:
100 mmol/L stock solution in dimethylsulfoxide of carba-
mazepine (Teva Pharmaceutical Industries, Petah Tikva,
Israel), 1.47 mol/L stock solution in water of levetiracetam
(AURO, Woodbridge, Canada), 0.5 mg/mL stock solution
in dimethylsulfoxide of clonazepam (Mylan, Canonsburg,
Pennsylvania), and 1 mol/L stock solution in water of val-
proic acid (Sigma, St Louis, Missosuri). The antiepileptic
drug (AED) solution was dissolved in fish water to reach
the final concentration.
2.7 | Transcriptomic assay, differential
expression assay, and pathway analysis
Two independent batches of 5 days postfertilization (dpf)
+/+ and −/− larvae were dissected to extract the whole
brains. Total RNA was extracted using a PicoPure RNA
extraction kit (Thermo Fisher Scientific, Waltham, Massa-
chusetts) following the manufacturer's standard protocol.
For each sample, RNA extraction was made from five
whole brains. Quality of total RNA was assessed with a
Nano bioanalyzer (Agilent Technologies, Santa Clara, Cali-
fornia), and all samples had an RNA integrity number > 9.
Library preparation was done with a TruSeq RNA Library
Prep Kit (Illumina, San Diego, California) as previously
described.17 Sequencing was performed using an Illumina
Hiseq 2000 as described previously.17 Between 67 and 80
million reads were generated for each sample. About 86%
of high‐quality reads were mapped onto the zv9 version of
the zebrafish genome (ensemble release 77) using TopHat
version 2.0.10 (Johns Hopkins University, Baltimore,
Maryland).
Differential gene expression analysis was assessed with
the DeSeq2 package using R software. Differential gene
expression was filtered on a false discovery rate > 0.05.
Pathway analysis was performed using DAVID bioinfor-
matics resources.
2.8 | Real‐time quantitative polymerase chain
reaction and real‐time polymerase chain
reaction
Quantitative polymerase chain reaction (qPCR) primers were
designed using the Universal Probe Library tool from Roche
(Basel, Switzerland). Reverse transcription was performed
from 500 ng of total RNA using the superscript VILO
RTmix (Invitrogen). qPCR was performed on 2 μL of 1:10‐
diluted cDNA using SYBR Green (Roche) on a LightCycler
480. The Polr2d gene (ENSDART00000108718) was used
as a reference gene for ddCt quantification.
2.9 | Immunohistochemistry and GAD65/67
quantification
Embryos were fixed as previously described.17 Embryos
were cut into 20‐μm‐thick sections on cryostat, mounted
on SuperFrost slides, and stored at −80°C. Immunohisto-
chemistry was performed as previously described17,18 with
anti‐GAD65/67 rabbit polyclonal antibodies (1:500,
ab11070; Abcam, Cambridge, Massachusetts), antigephyrin
(ab185930, rabbit polyclonal, 1:100, Abcam), or anti–
acetylated‐tubulin (1:1000, Sigma). Sections were analyzed
using a Leica (Wetzlar, Germany) TCS SP8 confocal scan-
ning system. Images were analyzed in Imaris 7.6.4 (Bit-
plane, Zurich, Switzerland). MeasurementPro's Filaments
(Bitplane), which automatically detect filament‐like struc-
tures, were used to outline and quantify the dendrites.
3 | RESULTS
3.1 | Gabra1−/− loss of function by CRISPR
KO leads to premature death
A single copy of the gabra1 gene can be found in the zeb-
rafish genome (ENSDARG00000068989), and it shows
>83% overall predicted amino acid identity with the
human protein (Figure 1A). In particular, the GABA bind-
ing site and the transmembrane domain show 95% and
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88% identities, respectively, when compared to the human
protein. Whole mount in situ hybridization revealed that
gabra1 transcripts accumulated in the central nervous sys-
tem from 18 hours postfertilization onward, with a strong
expression observed throughout the brain and spinal cord
at 48 hours postfertilization (Figure 1B). These results
suggest a robust evolutionary conservation of GABA
receptor A function, thus supporting the pertinence of
investigating GABRA1 function in relation with epilepsy in
zebrafish.
To generate zebrafish embryos with loss of gabra1
function, we targeted the GABA binding domain with a
specific guide RNA for CRISPR/CAS9 mutagenesis (Fig-
ure 1C). We selected a positive founder carrying
frameshifting mutation leading to a premature stop codon
at (extracellular) position 150. We confirmed the genomic
FIGURE 1 GABRA1 knockout leads to premature death in zebrafish. A, Human (top, ENST00000393943.9) and zebrafish
(ENSDART00000100000.4) GABRA1 protein sequences were aligned using Clustal W algorithm, and amino acid identity is indicated by
asterisks. Colons and dots indicate conservation between amino acid of strongly or weakly similar properties, respectively. The γ‐aminobutyric
acid (GABA) binding and transmembrane domains are highlighted in green and orange, respectively. The CRISPR‐targeted site is indicated with
a red star. B, Whole mount in situ hybridization against gabra1 mRNA showed a faint expression in the central nervous system at 18 hours
postfertilization (hpf) that increased in the developing brain at 24 and 32 hpf. The expression was broad, strong, and restricted to the brain at
48 hpf. C, CRISPR mutagenesis of the GABRA1 GABA‐binding domain coding sequence led to the A>T+CC mutation (mut). The mutation was
confirmed by Sanger sequencing. WT, wild‐type. D, Real‐time quantitative polymerase chain reaction analysis of RNAs from 5 days
postfertilization larvae (in triplicate with n = 7) shows a significant decrease of gabra1 mRNA expression in gabra1+/− (52.52% of WT ±
0.0327) and gabra1−/− (14.04% of WT ± 0.00058) larvae when compared to their WT siblings (one‐way analysis of variance and Tukey
multiple comparison test; ****P < 0.0001). E, The progeny of gabra1+/− individuals was genotyped by tail‐clipping at 1 week postfertilization
(wpf), raised separately according to their genotypes, and the survival of each class (+/+, +/−, −/−; n = 8) was monitored every week until
15 weeks of age
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sequence by Sanger sequencing and high‐resolution melting
assay (Figure 1C). Using real‐time qPCR, we observed that
gabra1 transcript accumulation was reduced by almost 50%
in gabra1+/− embryos and by >85% in homozygotes, the
likely result of nonsense‐mediated mRNA decay. We there-
fore predicted the mutation to lead to full loss of GABRA1
FIGURE 2 Gabra1−/− fish undergo evident generalized seizures upon light. A, Distance swam over 8 hours in the dark (left) or light (right)
by 5 weeks postfertilization (wpf) gabra1+/− or −/− juveniles revealed significant hypoactivity of gabra1−/− compared to their heterozygous
siblings (sib) in both light (t test, P < 0.03) and dark cycles (t test, P < 0.003). B, Measurements of the distance swam per 30‐second period
after light was turned on revealed a strong increase of 5.5 wpf gabra1−/− motility just after light was turned on and followed by a period of
immobility. C, Video frames of juvenile (5‐6 wpf) gabra1+/+ (top), +/− (middle), and −/− (bottom) siblings upon light exposure. Immediately
after light, gabra1−/− fish underwent a first tonic‐like phase characterized by arching of the body (arrows), uncontrolled twitching (as seen with
the red tracks), and loss of posture (arrowheads). After this first phase, which lasted a few seconds, gabra1−/− fish underwent a second, clonic‐
like phase, during which they underwent rapid and uncontrolled movements, fast muscle contractions, and whole‐body convulsions leading to a
whirlpool swimming pattern (tracks in red). Lastly, after about 1 minute of seizure, they entered a third, postictal phase, during which they
stayed immobile and breathed heavily for 3‐10 minutes. D, E, Maximum acceleration upon light of 4 days postfertilization (dpf) gabra1 embryos
(n = 96) showing an increased startle response to light of gabra1−/− specifically. Tracks of 3 seconds following light exposure show a
stereotyped pattern of +/+ (left), +/− (middle), and −/− (right) light response
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function in homozygotes. Although gabra1−/− embryos
developed and grew normally like their wild‐type siblings,
almost all homozygotes died prematurely between 7 and
10 weeks postfertilization (wpf; Figure 1E).
3.2 | Gabra1−/− juvenile fish exhibit seizures
upon light exposure
Because GABRA1 mutations have been reported to induce
juvenile myoclonic epilepsy,3,4 we monitored the swim-
ming behavior of 5 wpf juvenile fish during an 8‐hour
dark, 8‐hour light cycle, using an automated recording
chamber. Interestingly, we noticed that gabra1−/− larvae
were hypoactive (Figure 2A), but more importantly, we
noticed a drastic increase in the distance swam by gabra1−/−
juveniles at the exact time the light was switched on, fol-
lowed by a period of complete inactivity during the next
few minutes (Figure 1B). Careful observation indicated that
all gabra1−/− juveniles underwent intense seizures in the
seconds immediately after the lights were turned on (Fig-
ure 2C and Video S1). Interestingly, the seizures were
characterized by an initial phase with a series of short but
intense convulsions, which were followed a brief collapse,
a loss of swimming posture, and repetitive jerks of the
jaws. Then, in the following minute, the fish underwent a
second phase with rapid uncontrolled movements, fast mus-
cle contractions, and whole‐body convulsions, leading to
rapid and intense swimming. Specifically, we observed
“whirlpool” behavior, with fish swimming rapidly in cir-
cles, a pattern reminiscent of what is observed following
treatment with proconvulsant drugs such as pentylenetetra-
zol.19 We also witnessed seizures triggered by light in lar-
ger tanks in which mutant fish are swimming
uncontrollably throughout the water tank (Video S2). After
this two‐step seizure that is evocative of human tonic/clo-
nic episodes, gabra1−/− fish entered a third phase of freez-
ing during which they exhibited heavy gill breathing and
complete immobility for a few minutes.
As fully penetrant seizures were observed from 5 wpf
onward, we sought to determine the earliest stage at which
gabra1−/− zebrafish show epileptic features. Therefore, we
analyzed the response to light and swimming behavior of
embryos and found that gabra1−/− zebrafish larvae dis-
played increased swimming activity in response to light as
early as 4 dpf (Figure 2D and 2E). Before that age, +/+
and −/− embryos depict the same normal level of light‐
induced startle response (asterisks in Figure S1).
To confirm that the phenotype observed does not corre-
spond only to a hypermotility but rather to a genuine epilep-
tic behavior, we monitored the temporal and regional
neuronal activity following light exposure in gabra1+/+ ver-
sus gabra1−/− larvae (Figure 3A and 3B). To do so, we
crossed our gabra1 mutant line with the NeuroD:GCaMP6f
transgenic line that expressed a calcium‐dependent fluores-
cent protein in the neuronal population.15,20 We triggered the
seizure by switching on the laser after incubating the larvae
for at least 30 minutes in complete darkness, and we
observed an immediate burst of neuronal activity in both
optic tecta of −/− larvae. This activity is generalized
throughout the optic tecta and is intense compared to the
slight neuronal activity observed in siblings in response to
the laser light (Figure 3A). Interestingly, exposure to valproic
acid (VPA) rescues the gabra1−/− light‐induced neuronal
activity to the wild‐type level (Figure 3A). Quantification of
the fluorescent signal from the optic tecta showed a signifi-
cant increase in the neuronal activity of −/− larvae immedi-
ately after laser exposure and lasting for a few seconds
(Figure 3B). Such a generalized and synchronized burst of
neuronal activity in both optic tecta is never observed in sib-
ling larvae even after light exposure, and it is fully rescued
with exposure to a potent antiepileptic agent (VPA). Thus, it
confirms that the observed phenotype in gabra1−/− larvae is
associated with intense and generalized neuronal activity.
Until 2 to 3 wpf, gabra1−/− larvae only underwent
tonic‐like seizures in response to light, without the subse-
quent clonic‐like whirlpool behavior. However, even at
these early stages, the seizures in response to light stimulus
were evident (Video S3). Interestingly, we noticed that the
penetrance of the whirlpool phenotype increased with age,
with almost all embryos showing whirlpool swimming
from 6 wpf onward (Figure 3C). Although we did not
notice any specific sensitivity of gabra1 mutants to sound,
temperature, or sleep deprivation, we noticed an increase in
spontaneous generalized seizures upon stressful events (eg,
tank cleaning and introduction of a net into the tank) in
fish older than 7 wpf. This suggests that rather than being
specifically triggered by light, gabra1−/− epileptic seizures
can be provoked with specific starling stimuli (including
light). Lastly, we witnessed death following generalized
seizures in gabra1−/− juveniles from 4 wpf onward, with a
predominant occurrence between 6 and 7 wpf (Figure 3D,
Video S4). Occurring immediately after a seizure, this is
evocative of sudden unexpected death in epilepsy and is
consistent with the premature death observed in the
homozygous population from 6 wpf (Figure 1E).
3.3 | Differential attenuation of seizures by
known AEDs
We then tested the ability of known AEDs to rescue the
seizures. Following a 1‐day incubation with different
AEDs, we triggered a seizure with light and monitored
both tonic‐like phase (by measuring the motion tracks of
the startle response immediately upon light exposure, left
panels) and clonic‐like phase (by quantifying the distance
swam upon light exposure, graphs on right panels;
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FIGURE 3 Generalized neuronal activity in gabra1−/− following light exposure and sudden death following generalized seizures. A,
Gabra1+/− and NeuroD:GCaMP6f +/− were intercrossed, and neuronal activity was monitored under a confocal microscope at 8 days
postfertilization. After a period of 30 minutes in complete darkness, switching on the laser induced a broad neuronal activity in both optic tecta
in gabra1−/− (n = 12) compared to gabra1+/+ siblings (n = 10) that lasted for few seconds (arrows). The intense neuronal activity of −/− larvae
was rescued to wild‐type (WT) level after exposure to valproic acid (VPA; 50 μmol/L, n = 7). B, Fluorescence quantification in the optic tecta
before and after laser exposure shows a significant increase of fluorescence in −/− larvae compared to +/+ siblings. Each point corresponds to
the relative quantification of fluorescence from a frame with 400‐millisecond exposure. VPA treatment fully rescues the fluorescence back to the
WT level (Student t test: *P < 0.05, ** P < 0.01, ***P < 0.005). C, The whirlpool onset (ie, clonic‐like phase) increased with age, with a full
penetrance at 6 weeks postfertilization (wpf) onward. D, Sudden unexpected death in epilepsy (SUDEP) events were quantified and occurred
from 4 wpf onward only in gabra1−/− mutants. Of note is that data shown here correspond to the actual SUDEP events witnessed, but it is very
likely that it occurs in many more fish
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Figure 4). We found that VPA and clonazepam completely
abolished both phases of the seizures (Figure 4A and 4B,
left panels). Interestingly, calcium imaging showed that
VPA exposure rescues brain activity back to the same level
as wild type (Figure 3B), thus indicating that the positive
effect of VPA is not due to oversedation. Interestingly, we
found that levetiracetam and carbamazepine had a mild
effect on the first phase of the seizure (as shown by seizure
tracks, left panels in Figure 4A‐D) but only rescued the
clonic‐like phase, suggesting that their effect on gabra1−/−
generalized seizure is milder (Figure 4C and 4D, right pan-
els). This mild effect of carbamazepine is consistent with
previous studies in an scn1a mutant zebrafish model.21
We next examined whether larvae, rather than juvenile
fish, could be used for drug screening so that more biologi-
cal replicates could be used in a shorter time. Thus, we
tested the effects of the same four AEDs on young larvae.
Interestingly, overnight treatment with VPA, clonazepam,
or levetiracetam fully abolished this phenotype, as shown
by either quantification of acceleration (Figure 4E) or
visual inspection of the tracking records (Figure 4F). In
contrast, carbamazepine treatment was unable to fully alle-
viate the swimming behavior of gabra−/− larvae, although
the acceleration values were significantly reduced. These
results accurately matched those observed with juvenile
fish (compare Figure 4A‐D to Figure 4E and 4F), thus
demonstrating that the gabra1 line is a convenient tool for
AED screening as early as 4 dpf.
3.4 | Gabra1 loss of function does not modify
brain structure but alters developmental brain
transcriptome
Because gabra1−/− mutants display highly penetrant epilep-
tic seizures, we investigated whether they could depict a
defect in brain structure and/or neuronal content that may
explain their hyperexcitability. To do so, we checked the
main brain neuronal fibers by immunolabeling using an
FIGURE 4 Differential attenuation of seizures by known antiepileptic drugs (AEDs). Five to 6 weeks postfertilization wild‐type (+/+, n = 5)
or homozygous (−/−, n = 5) fish were incubated overnight with valproic acid (VPA; A), clonazepam (B), levetiracetam (C), or carbamazepine
(D). Both steps of the light‐triggered seizure were analyzed before and after the treatment using the track of single fish for 3 seconds following
light being switched on (left panels), as well as by quantifying the distance swam during the minute following light being turned on (right
panels). E, The increased acceleration of 4 days postfertilization (dpf) gabra1−/− embryos was differentially alleviated by the four tested AEDs
(n = 22 per assay). F, Stereotyped tracks of 4 dpf untreated gabra1−/− embryos and mutant embryos treated with the four AEDs. All drug
treatments were performed overnight with a final concentration of either 50 μmol/L VPA, 50 μmol/L clonazepam, 30 mmol/L levetiracetam, or
100 μmol/L carbamazepine. ns, not significant. *P value <0.05
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antibody against acetylated tubulin (Figure 5A). No major
loss of neuron fibers was observable even at closer zooms
in the optic tectum, which is a highly innervated region,
especially by inhibitory interneurons (right panel in Fig-
ure 4A). Moreover, we noticed no major difference in the
brain structure as revealed by cresyl violet staining (Fig-
ure 5B, upper panel) and no specific change in the neuronal
content after immunolabeling with anti‐HuC antibody (Fig-
ure 5B, lower panel). These results indicate that the main
brain structures and neuronal population are not obviously
affected by GABRA1 loss of function. However, in an
attempt to determine molecular defects, we dissected whole
brains from gabra1−/− embryos and their wild‐type siblings
and extracted total RNA for deep sequencing (Figure 5C).
Interestingly, transcriptome analysis identified 460 genes
that were either up‐regulated (251 genes) or down‐regulated
(209 genes) in gabra1−/− embryos when compared to their
wild‐type siblings (Figure 5C‐E, Table S1). The down‐ and
up‐regulation of some genes of interest were confirmed by
real‐time qPCR analyses (Figure S3). By performing gene
clustering and pathway analysis, and also using DAVID,22
we were able to identify the following clusters: ribosomal
subunits (65 genes), embryo development (21 genes), neu-
rogenesis (50 genes), synapse function/activity (36 genes),
GABA network (10 genes), and cell‐cell interaction (15
genes). Finally, we found many genes already related to
epilepsy (23 genes) or other neurological disorders (39
genes; Figure 5D and Tables S1 and S2).
In particular, we found many genes involved in axon
guidance to be misregulated in gabra1−/− brains (Fig-
ure S4A, Table S2). Moreover, the expression of many
genes involved in synaptic vesicle docking, priming, and
endocytosis was altered in mutant brains (Figures S4B and
5). Altogether, these results strongly suggest that GABRA1
loss of function induces transcriptional defects in a large
number of genes involved in early brain development.
More specifically, our transcriptomic analysis pointed to
a specific down‐regulation of many genes involved in
GABAergic synapse function (Figure S4D). Specifically, 3
GABA receptor subunits (besides GABRA1) were signifi-
cantly down‐regulated in gabra1−/− mutants. Also, neurex-
ophilin 2a (nxph2a) and neuroligins 2 and 4 (nlgn2, nlgn4)
were down‐regulated in mutant brains and these genes have
been shown to be important inducers and maintainers of
GABA synapses.23,24 Moreover, we noticed a down‐regula-
tion of the motor kinesin 5 (KIF5B) as well as its associ-
ated kinesin light chain 1a (KLC1A), both involved in the
trafficking of GABAA receptors at the postsynaptic mem-
brane.25,26 Our dataset also showed that the slc6a11b gene
encoding GABA transporter 3 (GAT3), which is expressed
in glial cells surrounding GABA synapses, was also down‐
regulated. Altogether, these results show that gabra1 loss
of function induced specific transcriptome down‐regulation
in components of synaptic GABA signaling in the larval
brain.
3.5 | Gabra1−/− embryos exhibit markedly
decreased inhibitory synapses throughout the
brain
Although we showed previously that the brain structure is
not altered by GABRA1 loss of function (Figure 5A and
5B), we sought for subtler consequences, specifically in the
inhibitory neuronal network as our transcriptomic data sug-
gested. Thus, we crossed the gabra1 line with the dlx5/6:
GFP transgenic line27 in which GABAergic interneurons
are fluorescently labeled in the brain. The distribution and
number of the GABAergic cell population are similar when
comparing gabra1−/− and sibling larval brains (Figure 6A
and 6B). However, because our transcriptomic data specifi-
cally identified members of the inhibitory synapses (Fig-
ure S4D), we analyzed the accumulation of glutamate
decarboxylase (GAD65/67), the enzymes involved in
GABA synthesis in presynaptic buttons of inhibitory
synapses, using an anti‐GAD65/67 antibody. Immunostain-
ing of larval brain sections from gabra1+/+ and gabra1−/−
embryos showed that accumulation of GAD65/67 proteins
was markedly decreased in mutants (Figure 6C‐G). Interest-
ingly, this reduction was seen throughout the brain, includ-
ing the telencephalon, optic tectum, hindbrain, and anterior
spinal cord. Quantification of GAD65/67‐labeled neurofila-
ments showed a decrease of >50% in −/− larval brains
compared to +/+ siblings (Figure 6G). Upon performing
three‐dimensional reconstructions of representative GAD65/
67+ punctae (Figure 6H, Videos S5 and S6), we observed
that the number of GAD65/67‐containing structures was
markedly reduced in gabra1−/− brains, suggesting a reduc-
tion in GABAergic presynaptic signaling. To confirm this
observation, we investigated the expression of gephyrin,
another marker of inhibitory synapses, as it anchors postsy-
naptic GABA receptors to the cytoskeleton.28 Consistently,
we noticed a decrease in the number of gephyrin‐positive
clusters in gabra1−/− brains compared to wild‐type siblings
(Figure 6I).
Altogether, these results indicate that, although GABRA1
loss of function does not affect the overall development of
the inhibitory cell population, GABRA1 is required for the
formation of GABAergic synaptic buttons as well as for
the establishment of the complex branching of inhibitory
synaptic network throughout the brain.
4 | DISCUSSION
Here, we showed in vivo evidence that GABRA1 loss of
function impacts neurodevelopment, specifically inhibitory
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FIGURE 5 Whole transcriptome deep sequencing revealed 460 genes differentially expressed in gabra1−/− brains, although brain structure
is not altered. A, Immunolabeling of 4 days postfertilization (dpf) whole gabra1 embryos using an antiacetylated tubulin recognizing neuronal
fibers. B, Longitudinal slices of 7 dpf gabra1 larvae stained with cresyl violet (top) or immunostained against HuC (bottom), showing no major
difference between mutants and siblings. DAPI, 4,6‐diamidino‐2‐phenylindole. C, Whole brains from 5 dpf embryos were dissected, and total
RNAs were extracted for subsequent deep sequencing. Using DESeq2, we identified 460 genes whose expression was significantly altered in
homozygous brains. DE, differential expression. D, Gene clustering analysis allowed the classification of a list of genes according to their
function. The full list is provided in Table S2. GABA, γ‐aminobutyric acid. E, Volcano plot showing each individual gene plotted according to
its log2 fold change (FC; x‐axis) and the −log10 P value (y‐axis). All differentially expressed genes with P < 0.05 are highlighted in yellow.
Those whose absolute fold changes were >1.5 or >2 are shown in orange and red, respectively. A full list of genes is provided in Table S1
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synaptic network wiring during embryogenesis. Thus, we
confirm that this neurodevelopmental aspect of the disease
is a main component of the epileptogenesis process and
should be considered for further therapeutic strategies.
Interestingly, our unbiased transcriptomic analysis
revealed gene families whose expression was altered in
gabra1−/− brains. The main results from this analysis
revealed that several key genes involved in axon guidance
were misregulated in gabra1−/− brains. In particular, genes
encoding protocadherins, ephrin/ephrin receptors, and sema-
phorins were either up‐ or down‐regulated in mutant brains,
suggesting that axon guidance and/or axonal branching as
well as neural connectivity are subtly affected in mutants.
This could lead to impaired synapse formation and function,
as suggested by changes in the expression of several genes
involved in synaptic vesicle trafficking (Figure S4B). Con-
sistently, we observed that GABAergic projections were less
arborized in mutant brains than in those of wild‐type
embryos, supporting possible axon guidance alterations.
Interestingly, these changes in inhibitory synaptic connectiv-
ity seem to be independent from the development of the
GABAergic neuron population, because the number of those
cells is unchanged in gabra1−/− brains. Thus, a likely sce-
nario is that GABRA1 function is specifically required for the
establishment of inhibitory synapses in already differentiated
GABAergic neurons. More specifically, functional
GABRA1‐dependent GABA signaling may be essential dur-
ing neurodevelopment for the correct temporal and regional
expression of specific axon guidance cues such as semaphor-
ins, plexins, and ephrins. Interestingly, semaphorins, ephrins,
and plexins have already been shown to be essential players
for the correct establishment of specific synapses throughout
neurodevelopment but also postnatally. Moreover, mutations
in some of these genes are known to cause epilepsy.29–33
However, future work is needed to investigate the exact
genetic and molecular mechanisms linking GABRA1‐KO to
the reduction of GABAergic synaptic connections.
Consistently, GABA signaling has already been shown
to regulate GABAergic synaptogenesis during neurodevel-
opment. Different studies have shown that the integrity
of GABA signaling is necessary for proper regulation of
synaptogenesis during neurodevelopment.34 In particular,
postsynaptic GABAA receptors are able to initiate the
formation and the maintenance of functional GABAergic
synapses.35 Because the alpha 1 subunit is known to be
a major subunit composing the synaptic pull of GABA
receptors, GABRA1 loss of function is likely to disturb
GABAergic synaptogenesis, which is consistent with our
findings. Moreover, Oh et al36 showed that exogenous
local puffs of GABA in the developing mouse cortex are
able to generate de novo GABAergic synaptogenesis,
supporting the positive effect of GABA for the develop-
ment of inhibitory synapses. Altogether, our in vivo
results are consistent with previous work and connect the
role of GABA in neurodevelopment with epilepsy
pathogenicity.
Surprisingly, our transcriptomic assay also showed that
the expression of many epilepsy‐related genes is shifted to
proepileptic levels (either over‐ or down‐regulated) in
gabra1−/− brains (Figure S4). In other words, genes for
which loss of function causes epilepsy in patients (dnm1a,37
cntn2,38 gabab1b/gabab2,2,39 gabrg2,2,40 kcc2 [slc12a5b],41
atp2b3,42 kcnc1,43 kcnj10,44 gat3 [slc6a11]45 and kif546) were
significantly down‐regulated in our dataset, whereas cac-
na2d2a, a gain of function of which causes epilepsy,47 was
up‐regulated in gabra1−/− brains. Thus, these results show
in vivo that, notwithstanding the down‐regulation of gabra1
itself, loss of GABRA1 function significantly modifies the
expression of a broad set of proepilepsy‐related genes.
In summary, our data confirm in vivo the evidence for
a developmental aspect of epileptogenesis. Interestingly,
the neurodevelopmental defects of GABRA1‐related epi-
lepsy are an important aspect for the design of new treat-
ment for epileptic patients. We propose that therapeutic
strategies should not only aim at counterbalancing the
activity of the mutant channel, but should be developed in
combination with approaches to restore or at least com-
pensate the developmental neurogenic defects we describe
here. More research needs to be done to understand the
exact neurodevelopmental abnormalities causing epilepsy
and to restore them as early as possible rather than treat it
symptomatically at later stages.
At this juncture, our gabra1 mutant line is an advanta-
geous model for future studies of epileptogenesis.
Although several genetic models of epilepsy have already
been generated in zebrafish, the epileptic phenotype is
rarely as evident as it is in gabra1−/− fish described here.
The seizures described in this study were evident in all of
the gabra1−/− juvenile fish examined and could be trig-
gered by light, a fully physiological and otherwise harm-
less stimulus. Interestingly, although we did not notice an
effect of stroboscopic light exposure (6‐60 Hz), future
work could investigate in more detail the effect of con-
ventional photic stimulation on seizure incidence in our
model. We also have optimized our gabra1‐KO mutant
line as a powerful model to eventually perform large drug
screens. AED efficacy can first be assessed in a standard-
ized and high‐throughput fashion with gabra1−/− larvae
(4 dpf) and later confirmed with juvenile fish (5‐6 wpf)
that depict obvious generalized seizures, a funnel strategy
that should help to narrow down positive hits more
quickly and efficiently. As genetic generalized epilepsies
account for about 15%‐20% of all epilepsies,1 our model
should be useful in the future to screen new candidate
antiepileptic molecules that are particularly needed in the
context of refractory epilepsies.
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FIGURE 6 Reduction of inhibitory synaptic connectivity in gabra1−/− mutants. A, Confocal imaging of 8 days postfertilization (dpf) larval
brains from gabra1 × dlx5/6:GFP transgenic lines. B, Quantification of the number of green fluorescent protein (GFP)+ cells at the commissure
(top) or projecting to the optic tectum (bottom). ns, not significant. C‐F, Fluorescent immunodetection of GAD65/67 (green) combined with 4,6‐
diamidino‐2‐phenylindole (DAPI) labeling on cryostat sections of different brain regions from 6 dpf gabra1+/+ and gabra1−/− zebrafish embryos
(scale bars = 10 μm): telencephalon (C), anterior part of optic tectum (D), posterior part of optic tectum (E), spinal cord (F). G, Quantification of
GAD65/67‐labeled neurofilaments (n = 3, Student t test: **P = 0.0019). H, Imaris‐reconstructed three‐dimensional image with Gad65/67 shown
in green and the nucleus (DAPI) shown in blue. Scale bar = 2 μm. I, Sagittal sections of 6 dpf gabra1+/+ and gabra1−/− embryos hybridized
with an antibody directed against postsynaptic density gephyrin (green) and nuclei stained with DAPI (blue; scale bar = 50 μm). Magnified
views of the regions boxed in white and red rectangles are shown (scale bar = 10 μm). A decreased accumulation of gephyrin expression was
observed in gabra1−/− mutants. For each imaging, the same field of observation is shown for +/+ and −/− larvae, thus avoiding regional bias
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